During the past decade, Onomichi General Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Onomichi General Hospital" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Cancer of Bile Duct" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Onomichi General Hospital" in a lesser frequency.

Most popular intervention types in "Onomichi General Hospital" are "Drug" (4 trials), "Other" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ontamalimab" (4 trials), "Placebo" (4 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "PTFE Covered ComVi [full covered] Biliary Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Onomichi General Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Onomichi General Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Onomichi General Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Onomichi General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".